Server was unable to process request. ---> The data types ntext and varchar are incompatible in the equal to operator. Incorrect syntax near ')'. Incorrect syntax near the keyword 'declare'. Khandwala Securities Limited.
NIFTY
-17.00  -0.19%
 9119.40
S&P BSE SENSEX
102.11  0.35%
 29467.41
Aurobindo Pharma Ltd.
NSE : AUROPHARMA BSE : 524804 ISIN code : INE406A01037
on 21-Apr-2017
NSE
-1.2    -0.19%
Rs. 633.20
 
Days Low
Rs. 630.3
Days High
Rs. 643.9

Open Rs. 640
 
52 week Low
Rs. 622
52 week High
Rs.895
 
 
Bid :                 633.50 (15)
Offer :        0.00 (0)
BSE
Rs.633.30
0    0%
on 21-Apr-2017
BSE
0    0%
Rs. 633.30
 
Days Low
Rs. 630.1
Days High
Rs. 643.95

Open Rs. 639
 
52 week Low
Rs. 621.9
52 week High
Rs.895
 
 
Bid :                 633.50 (15)
Offer :        0.00 (0)
NSE
Rs.633.20
-1.2    -0.19%
 
 
Last Price (Rs.)  633.30 Value  147973771.00
Net Change (Rs.)  0.00 Best Buy  633.50
Volume  232941 Best Sell  0.00
Prev.Close (Rs.)  633.30 Best Quantity  15
Open (Rs.)  640.00 Sell Quantity  0
High (Rs.)  643.90 52-Week High (Rs.)  895.00
Low (Rs.)  630.30 52-Week Low (Rs.)  622.00
Face Value (Rs.)  1 Market Cap.(Rs/ Mn)  371039.33
 
BSE
You need to upgrade your Flash Player
 
Financial (Rs .in Million)
Balance Sheet
Share Capital585.20 292.00 291.50 
Share Capital585.20 292.00 291.50 
Share Capital585.20 292.00 291.50 
Share Capital585.20 292.00 291.50 
Share Capital585.20 292.00 291.50 
Currents Investments0.20 196.40 0.30 
More> 
 
Top 5 PeerCompanies * (Rs .in Million)
Company NameLTP* M.CapBVP/EDiv.Yield
Sun Pharma Inds. 640.05 1535666 89.42 0.00 0.16
Lupin 1409.10 636317 313.98 22.01 0.53
Cadila Healthcare 449.90 460582 64.69 23.30 0.71
Cipla 563.40 453261 157.30 32.38 0.35
Dr. Reddys Lab 2608.70 432370 683.86 32.86 0.77
 
Mutual Funds Holdings
 
Quarterly Result
(Rs .in millions)Dec 2016Sep 2016Jun 2016
Net Sales25213.7024101.6023897.60
Operating Profit6634.806278.105873.90
PBDT6532.806158.805734.20
Net Profit4410.204192.403910.30
More> 
 
Company News
4/19/2017 12:00:00 AM
Updates
4/19/2017 12:00:00 AM
USFDA issues 6 observations to Aurobindo Pharma’s Hyderabad facility
4/10/2017 12:00:00 AM
Aurobindo Pharma informs about investor grievance report
More>
 
Ratios
   Earnings Per Share (Rs)27.68 
   Book NAV/Share(Rs)116.38 
   PAT Margin (%)17.37 
   Asset Turnover(x)0.84 
   PER(x)26.92 
   Yield(%)0.34 
   EV/Core EBITDA(x)17.70 
   M Cap / Sales4.76 
   Net Sales Growth(%)13.23 
   PAT Growth(%)6.81 
   Total Debt/Equity(x)0.49 
   Current Ratio(x)1.54 
   Quick Ratio(x)1.00 
   Total Debt/Mcap(x)0.08 
More>